Sanjay K. Sehgal
Founder Managing Partner & CEO
Sanjay brings nearly 30 years of global private equity and venture capital experience, having led or co-led investments worth close to $400 million of equity.
He is the former Chairman of Seraxis, a stem cell research company focused on treating diabetes, operating out of the US and Singapore.
He is currently a Board member of LiPlasome Pharma ApS, Denmark - an oncology drug delivery company.
He was a Member of The President's Leadership Council at the Hepatitis B Foundation/Baruch S. Blumberg Institute/Pennsylvania Biotechnology Center, in Doylestown, PA.
Sanjay was a Senior Management Leadership Mentor to Sonnet BioTherapeutics, Inc, a Nasdaq-listed company.
He was a Senior Advisor to Visterra, Inc, a biotech spinout from MIT, which was acquired by Otsuka Japan.
He was a Board Member and Chairman of the Audit Committee of an Australian-listed company, ITL Limited.
He is based out of Princeton, NJ and Singapore.
Sanjay was a Partner at Schroder Capital Partners (Asia), based out of Singapore and Hong Kong where he helped pioneer the entry of the Schroder private equity Funds' into the Healthcare and Life Sciences domain, and geographically into India. Sanjay was an active Board member of private and listed companies in which the Schroder Funds' invested. He was a member of the Investment Committee, for the Schroder Funds' which had $725 million under management and was keenly involved in the negotiated deals in India, USA, Latin America, China, Australasia and southeast Asia.
Prior to joining Schroder Capital Partners, Sanjay worked at LEK Consulting in London and Boston. Previously, he was a Member of Technical Staff at GTE Laboratories (now Verizon) in USA.
Sanjay has a MBA in Finance and Management, with distinction, from The Wharton School, Philadelphia, PA; an MSc in Telecommunications from Columbia University, NY; and a Bachelors degree in Technology (Elec. Engg.), from the Indian Institute of Technology (IIT Bombay).
Sanjay was elected as Hon. Secretary, Singapore Venture Capital & Private Equity Association for 2005 and as Hon. Treasurer in 2004.
He has spoken at numerous healthcare and private equity conferences around the globe.